Quantoom Bioscience News Today

At the 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries’ (LMICs) capacity to develop high-quality, lifesaving vaccines at scale.

MRNA vaccines have simpler research and manufacturing processes than traditional vaccines, so expanding access

Around 99% of doses that are administered on the continent are imported. To address this problem, vaccine manufacturing facilities in Senegal, Rwanda, and South Africa are showing interest in a technology that reduces production costs and gets around patent barriers

Today at the 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, announced new investments to...

DAKAR, Senegal, October 9 2023 -/African Media Agency (AMA)/- Today at the 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries’ (LMICs) capacity to develop high-quality, lifesaving vaccines at scale. […]

The Co-chair of the Bill & Melinda Gates Foundation, Bill Gates on Monday, announced new investments to advance access to mRNA research

CPHI Barcelona announces the finalists for the upcoming CPHI Pharma Awards, which will be hosted on the opening day (24th October, 2023) of the world’s largest pharma event at the Fiera Barcelona. The shortlist was whittled down from more than 180 entries across 12 categories. Innovations cover the full ...

/PRNewswire/ -- MinervaX, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), today announces...